Top compounds associated with response to GDF5OS


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.065 0.09
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.09
mRNA Sorafenib GDSC1000 pan-cancer AAC 0.089 0.1
mRNA ML311 CTRPv2 pan-cancer AAC -0.057 0.1
mRNA UNC1215 GDSC1000 pan-cancer AAC -0.056 0.1
mRNA Vorinostat CTRPv2 pan-cancer AAC -0.057 0.1
mRNA PD-0332991 GDSC1000 pan-cancer AAC -0.056 0.1
mRNA GSK1070916 GDSC1000 pan-cancer AAC -0.051 0.1
mRNA SB52334 GDSC1000 pan-cancer AAC -0.053 0.1
mRNA Epothilone B GDSC1000 pan-cancer AAC -0.056 0.1
Download CSV